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Abstract - Wnt signaling functions in numerous cellular activities such as cell fate determination, patterning, and migra-
tion in embryogenesis, apoptosis, etc. In this study, we used quercetin and lithium chloride to investigate modulations of 
the Wnt signaling pathway in human pluripotent embryonal carcinoma NT2/D1 cell line. First, we optimized conditions 
for NT2/D1 cell treatments with quercetin and lithium chloride and assessed their cytotoxic effects on the cells, cell vi-
ability and proliferation rate. Our results showed that induction of cell death by quercetin and LiCl is p53-dependent in 
NT2/D cells. We also examined the degree of Wnt signaling modulations by analyzing the expression of c-myc, a well-
known Wnt signaling target gene. Since the retinoic acid induction of NT2/D1 cells is good in an in vitro model system for 
human neural differentiation, studying Wnt signaling modulation in NT2/D1 would contribute to a better understanding 
of the mechanisms involved in neural stem cell maintenance and human neural development. 
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INTRODUCTION
NT2/D1 is the most widely characterized human EC 
(embryonal carcinoma) cell line (Andrews, 1984). 
Due to its similarity to human embryonal stem cells 
(ES) (Freemantle et al., 2002) and their potential to 
differentiate into CNS (central nervous system) neu-
rons  upon  treatment  with  RA  (retinoic  acid),  the 
NT2/D1 cell line provides an excellent model system 
for studying human neural differentiation (Misiuta 
et al., 2006). It was shown previously that the expres-
sion of multiple Wnt signaling molecules is changed 
during neuronal differentiation of NT2/D1 cells (Ka-
toh, 2002).  
Wnt genes function in numerous cellular activi-
ties such as cell fate determination, patterning, and 
migration  in  embryogenesis,  apoptosis,  etc  (Reya 
and Clevers, 2005). Mutations in Wnt genes or com-
ponents of the Wnt pathway lead to specific devel-
opmental  defects,  while  various  human  diseases 
are caused by abnormal Wnt signaling (Logan and 
Nusse, 2004; Willert and Jones, 2006). In addition, 
Wnt signaling is critical for controlling the initiation 
and progression of many types of cancer (Reya and 
Clevers, 2005). 
Wnt signaling is initiated when Wnt ligands 
engage their cognate receptor complex consisting 
of a receptor of the Frizzled family and a mem-
ber of the LDL receptor family (Reya and Clevers, 
2005). The central player in the canonical Wnt sig-
naling pathway is a cytoplasmic protein β-catenin 
whose  stability  is  regulated  by  the  destruction 
complex  (Cadigan  and  Liu,  2006;  Mareel  et  al., 
1997). In the absence of Wnt signals, newly syn-
thesized  β-catenin  is  trapped  in  a  destruction 
complex consisting of adenomatous polyposis coli 
(APC) and axin. Casein kinase 1a (CK1a) and gly-
cogen synthase kinase-3b (GSK-3b) reside in the 202 MARIJA MOJSIN ET AL.
destruction complex and phosphorylate β-catenin, 
targeting it for proteasomal degradation (Reya and 
Clevers, 2005). When Wnt receptors are engaged, 
the kinase activity of the destruction complex is 
inhibited by a mechanism involving Dishevelled 
(Dsh) protein. This leads to the accumulation of 
cytoplasmic  β-catenin  and  its  translocation  into 
the nucleus where it interacts with TCF/LEF tran-
scription  factors  and  activates  Wnt  target  genes 
(Eastman and Grosschedl,  1999;  Kormish  et  al.; 
Park et al., 2005).
In the last couple of decades, substantial efforts 
have been made towards studying the importance 
of the Wnt signaling pathway in numerous cellular 
processes. One of the approaches is to modulate 
the Wnt pathway by blocking or mimicking Wnt/β-
catenin-signaling components. For instance, quer-
cetin has been frequently used as an inhibitor of 
the Wnt pathway (Park et al., 2005; Tomasoni et 
al.). This flavonoid, commonly present in plants, 
inhibits β-catenin/TCF signaling by decreasing the 
nuclear β-catenin and TCF proteins (Park et al., 
2005). The mechanism of Wnt pathway inhibition 
is probably responsible for quercetin’s antitumor 
activity. It has been used in clinical trials in can-
cer patients (Ferry et al., 1996). On the other hand, 
previous studies have demonstrated that lithium 
chloride, a simple cation used for the treatment of 
bipolar disorder, mimicked the effect of Wnt sig-
naling (Jope, 2003; Manji et al., 2000). This is ac-
complished by inhibition of GSK-3β, which leads 
to  the  accumulation  of  β-catenin  and  increased 
transcription of its target genes (Manji et al., 2000; 
Misiuta et al., 2006). 
The ultimate responses to modulations of Wnt/
β-catenin signaling are observed as changes in gene 
expression.  In  this  regard,  numerous  target  genes 
downstream of Wnt/β-catenin have been character-
ized in diverse types of cells and used as indicators of 
Wnt signaling activity (Huang and He, 2008; Mac-
donald et al., 2007; White et al., 2007). One of the 
genes activated by the β-catenin/TCF pathway is c-
myc, whose expression is widely used for monitoring 
the up- or downregulation of Wnt signaling (Park et 
al., 2005)
P53 is a tumor suppressor protein with strong 
antiproliferative and antiproapoptotic activities. In 
many cell types, p53 controls apoptosis and regu-
lates cell cycle arrest at G1 and G2 (Lin et al., 1992; 
Sugimoto et al., 2006; Vousden, 2006). The linkage 
between p53 and Wnt signaling has been reported 
previously in mESCs and cancer cell lines (Ilyas, 
2005;  Lee  et  al.,  2010).  Wnt  signaling  regulates 
p53  expression  by  increasing  p53  levels  in  some 
cell types and decreasing p53 in others (Mao et al., 
2001). In addition, it has been shown that the tumor 
suppressor protein p53 is involved in the regulation 
of Wnt signaling. p53 activates the expression of 
E3 ligase of β-catenin and simultaneously regulates 
the expression of many genes in the Wnt signaling 
pathway (Tell et al., 2006). In addition, interaction 
between  p53  and  GSK3b  links  the  Wnt  pathway 
with the Akt/PKB cell survival pathway. The balance 
between Wnt signaling, p53 and Akt may mediate 
whether a stimulated cell undergoes apoptosis, cell 
cycle arrest or transformation (Tell et al., 2006). Ac-
cordingly, the expression of p53 is used for the as-
sessment of apoptosis-mediated cell death.
In this study, we used quercetin and lithium chlo-
ride to investigate modulations of the Wnt signaling 
pathway in the NT2/D1 cell line. First, we optimized 
conditions for NT2/D1 cell treatments with querce-
tin and lithium chloride and assessed their cytotoxic 
effects on NT2/D1 cell viability and proliferation rate. 
Our results showed that the induction of cell death 
by quercetin and LiCl is p53-dependent in NT2/D 
cells. We also examined the degree of Wnt signaling 
modulations  under  these  experimental  conditions 
by checking the expression of c-myc, a well-known 
Wnt-signaling target gene. These analyses allowed us 
to determine the optimal concentrations of quercetin 
and lithium chloride for the modulation of canonical 
Wnt signaling in NT2/D1 cells. We have identified 
the dosages of quercetin and LiCl that effectively in-
hibit or stimulate Wnt signaling but have mild effect 
on cell viability and proliferation.MODULATIONS OF WNT SIGNALING IN NT2/D1 CELLS 203
MATERIALS AND METHODS
Cell culture
NT2/D1  cells  were  maintained  as  described  (An-
drews,  1984).  The  cells  were  grown  in  Dulbecco’s 
modified Eagle’s medium (DMEM; Gibco) supple-
mented with 10% fetal bovine serum (FBS; Gibco), 
1%  Glutamax  (Gibco),  1%  antibiotic  (penicillin-
streptomycin; Sigma) and 0.1% antimycotic (ampho-
tericin; Gibco) at 37°C under humidified 10% CO2 
and 91% air at 1 atmosphere. 
MTT test
NT2/D1 cells were plated in triplicate in 96-well 
microtiter  plates  at  a  density  of  5x105 cells  and 
incubated  in  the  presence  of  100  µl  of  medium 
supplemented  with  increasing  concentrations  of 
quercetin (40 µM, 70 µM and 100 µM; Sigma) or 
LiCl (7 mM, 10 mM and 20 mM; Sigma Aldrich). 
After 24 h, the medium was removed and the cells 
were incubated in 0.5 mg/ml MTT for 2 h at 37°C. 
Metabolically active mitochondrial dehydrogenas-
es convert the tetrazolium salt MTT to insoluble 
purple formazan crystals at a rate that is propor-
tional to cell viability (Tada et al., 1986). After re-
moval of the MTT media, 100 µl of DMSO (Sigma) 
was added to each well, to lyse the cells and solu-
bilize the formazan crystals formed. Absorbance 
was measured at 620 nm using a plate reader. Un-
treated negative controls were run together with 
treated cells. 
Western blot analysis
Whole cell lysates were prepared from either NT2/
D1 cells alone, or cells treated for 24 h with different 
counteractions of quercetin or LiCl (as described in 
the previous section) using NP-40 buffer [20 mmol/L 
Tris-HCl (pH 8.0), 5 mmol/L EDTA, 150 mmol/L 
NaCl, 1% NonidetP-40, 10% glycerol and Protease 
inhibitor cocktail (Roche Diagnostics GmbH, Ger-
many)].  Western  blots  were  performed  using  anti 
c-myc (9E10) (Santa Cruz Biotechnology), anti-p53 
(DO1) (Gene Spin), anti α-tubulin (DM1A) (Calbi-
ochem), and anti-GAPDH (AM20337PU-S) (Acris 
Antibodies, Inc).
RESULTS AND DISCUSSION
Quercetin inhibits NT2/D1 cells proliferation in a 
p53-dependent manner
In order to assess the effect of quercetin on the viabil-
ity and proliferation of NT2/D1 cells, the cells were 
treated with three different concentrations of quer-
cetin, 40 μM, 70 μM and 100 μM, for 24 h. As shown 
in Fig. 1A, 40 μM quercetin had no effect on NT2/
D1  cell  proliferation,  while  higher  concentrations 
(70 μM and 100 μM) significantly decreased the per-
centage of viable cells by approximately 40-60%, in 
a dose-dependent manner (Fig. 1A). There is no lit-
erature data for NT2/D1 cell viability after quercetin 
treatments but our results are similar to data obtained 
with other cancer cell lines. Numerous studies have 
reported that quercetin inhibits cell proliferation in a 
time- and dose-dependent manner in various human 
cancer cell lines, esophageal (Cheong et al., 2004), 
lung (Nguyen et al., 2004), colon (Salucci et al., 2002), 
breast (Choi et al., 2001), prostate (Yuan, 2005) and 
leukemia (Kuo et al., 2002). Quercetin shows chem-
opreventive activity and prevents the development of 
cancer in a variety of laboratory animal models, such 
as AOM (azoxymethane)-induced colon cancer in 
rats and mice, DMBA (dimethylbenz[a]anthracene)-
and NMU (N-nitrosomethylurea)-induced mamma-
ry tumors in rats (Deschner et al., 1993; Verma et 
al., 1988; Yang et al., 2000). In addition, quercetin is 
used in clinical treatments in cancer patients (Ferry 
et al., 1996).
To investigate whether the decrease in the prolif-
eration rate of NT2/D1 cells treated with quercetin 
was result of apoptosis-mediated cell death, we as-
sayed the expression of p53, an apoptosis mediator 
(Fig. 1B). The tumor suppressor gene p53 is regarded 
as a key factor in a balance between cell survival and 
cell death by the regulation of both the G1 and G2/M 
portions of the cell cycle (Agarwal et al, 1995). Our 
results show that the p53 protein level significantly 
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100 μM quercetin (Fig. 1B). These data indicate that 
quercetin induced p53-mediated cell cycle arrest and 
apoptosis in NT2/D1cells. 
The same effect was observed in human breast 
cancer MDA-MB-453 cells (Choi et al., 2008) and 
HepG2 cells (Choi et al., 2008): quercetin signifi-
cantly  inhibited  cellular  proliferation  and  induced 
cell cycle arrest and apoptosis. The molecular mecha-
nism that underlies quercetin-induced cell cycle ar-
rest and apoptosis in HepG2 cells is p53 stabilization 
at both mRNA and protein levels (Tanigawa et al., 
2008). 
Fig. 1. Quercetin decreases the proliferation rate of NT2/D1 cells 
in a p53-dependent manner.
(A) MTT proliferation assay of NT2/D1 treated with 40, 70 and 
100 μM quercetin for 24 h. The results are shown as percent-
ages of the negative control, untreated NT2/D1 cells. Values are 
presented as the means ±S.E.M. of at least three independent ex-
periments. Mean values of relative proliferation rates were com-
pared using Student’s t test. Values of p<0, 05 are presented by 
*. (B) Western blot analysis of p53 protein expression in NT2/
D1 cells treated with 40, 70 and 100 μM quercetin for 24 h. The 
level of GAPDH was used as a control for equal amounts of input 
proteins.
Fig. 2. LiCl decreases the proliferation rate of NT2/D1 cells in a 
p53-dependent manner.
(A) MTT proliferation assay of NT2/D1 treated with lithium 
chloride-7, 10 and 20 mM, for 24 h. The results are shown as per-
centages of the negative control, untreated NT2/D1 cells. Values 
are presented as the means ±S.E.M. of at least three independent 
experiments.  Mean  values  of  relative  proliferation  rates  were 
compared using Student’s t test. Values of p<0, 05 are presented 
by *. (B) Western blot analysis of p53 protein expression in NT2/
D1 cells treated with 7, 10 and 20 mM lithium chloride for 24 h. 
The level of GAPDH was used as a control for equal amounts of 
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Lithium chloride inhibits NT2/D1 cells proliferation 
in p53-dependent manner
In the majority of previous studies, NT2/D1 cells 
were treated with low, clinically applicable doses of 
LiCl (0,125 mM-1 mM) because of its therapeutic 
relevance in bipolar disorder treatment. Treatment 
with low LiCl doses for 24 h significantly increased 
NT2/D1  cell  proliferation,  while  concentrations 
around ~10 mM showed no difference in the pro-
liferation rate compared to untreated cells. In our 
experiments, NT2/D1 cells were treated with three 
concentrations of LiCl, 7 mM, 10 mM and 20 mM, 
for 24 h. The obtained data support previously de-
scribed results (Hill et al., 2008; Misiuta et al., 2006) 
since the treatment of NT2/D1 cells with 7 mM and 
10 mM LiCl was observed not to have an effect on 
the cell proliferation rate (Fig. 2A). Literature data 
showed that a concentration of LiCl ranging from 
10 mM to 100 mM exhibited high cytotoxity with 
a significant decrease of NT2/D1 cell proliferation 
with IC50 that is about 70 mM (the concentration 
of an agent that gives a half-maximal response). In 
agreement with these data, we have shown that 20 
mM LiCl significantly decreased the NT2/D1 cell 
proliferation  rate  (approximately  30%)  (Fig.  2A). 
Unlike quercetin, lithium chloride can induce dia-
metrically opposite effects on cell proliferation in 
different cell types. It has been reported that lithium 
chloride promotes proliferation and has antiapop-
totic,  especially  neuroprotective,  effects  in  many 
experimental settings (D’Mello et al., 1994; Hongis-
to et al., 2003; Kang et al., 2003; Welshons et al., 
1995). 
However, lithium is not always a neuroprotectant 
(Song et al., 2004). It promotes apoptosis that is me-
diated by a death domain-containing receptor and 
facilitates Fas-induced caspase activation in neural 
cells (Song et al., 2004). The factors responsible for 
these variations in cell response are unknown but 
may be influenced by differences in the underlying 
genetic background of different cell lines.
In addition, lithium chloride can also induce ap-
optosis in certain cell types including COS7 monkey 
kidney cells and a variety of human cells, e.g. HL-60 
promyelocytic leukemia cells, 293 embryonic kidney 
cells, K562 erythroleukemia cells and immature cer-
ebellar granule cells (D’Mello et al., 1994; Madiehe et 
al., 1995; Tang and He, 2003; van Gijn et al., 2001).
The main cellular target of lithium chloride is 
GSK-3, a kinase that phosphorylates several cellular 
substrates, including Mdm2 (Fiol et al., 1994; Kulik-
ov et al., 2005; Saksela et al., 1992), a ubiquitin ligase 
of the p53 tumor suppressor protein (Brooks and Gu, 
2006). Accordingly, inhibition of GSK-3 leads to the 
accumulation of p53 (Kulikov et al., 2005). Since p53 
has strong antiproliferative and proapoptotic activi-
ties (Vousden, 2006), we wanted to check whether 
the  lithium-induced  decrease  in  the  proliferation 
rate of NT2/D1 cells is p53-dependent.  
Our results suggest that LiCl induces a p53-de-
pendent decrease in the NT2/D1 cell proliferation 
rate since all three concentrations of LiCl increased 
the p53 protein level in the treated NT2/D1 cells (Fig. 
2B). Literature data show that LiCl induces p53 stabi-
Fig. 3. Western blot analysis of c-myc protein expression in NT2/D1 cells treated with: (A) 40, 70 and 100 μM quercetin and (B) 7, 10 
and 20 mM lithium chloride for 24 h. The level of α-tubulin was used as a control for equal amounts of input proteins.206 MARIJA MOJSIN ET AL.
lization by affecting the levels of protein, not mRNA, 
in primary endothelial cells, leading to G2/M arrest 
of these cells (Hossein et al., 2012). Also, lithium 
induced  an  increase  in  p53  expression  in  human 
melanoma cells (Smalley et al., 2007).
Quercetin and lithium chloride modulate Wnt  
signaling in NT2/D1 cells
Quercetin has been recognized as potent inhibitor of 
β-catenin/Tcf signaling. Its inhibitory mechanism is 
related to the decreased β-catenin and Tcf-4 protein 
levels in the nucleus, which lead to the downregula-
tion of target genes. In order to investigate whether 
applied treatments with quercetin modulate the ca-
nonical Wnt signaling pathway in the NT2/D1 cell 
line, we examined the expression of c-myc, a well-
known β-catenin/Tcf signaling target gene. Our re-
sults show that increased concentrations of quercetin 
downregulate c-myc protein expression in a dose-de-
pendent manner in NT2/D1 cells (Fig. 3A), suggest-
ing that this agent efficiently inhibits the β-catenin/
Tcf signaling pathway. At 40 μM quercetin no sig-
nificant difference in the c-myc protein level was de-
tected compared to untreated cells. Higher quercetin 
concentrations (70 and 100 μM) decreased and com-
pletely abolished c-myc expression (Fig. 3A).
These results are in concordance with previously 
published data. Quercetin at concentrations ranging 
from 40 μM to 100 μM significantly decreased c-myc 
protein expression in a dose-dependent manner in 
the  human  gastric  carcinoma  cell  line,  MGC-803 
(Wang et al., 2006). In SW 480 colon cancer cells, 
100 μM quercetin treatment decreases c-myc mRNA 
and completely abolishes c-myc protein expression 
(Park et al., 2005). 
In  our  experimental  setting,  LiCl  increased  c-
myc protein expression in a dose-dependent manner 
(Fig. 3B). The concentration of 7 mM LiCl has no 
effect on c-myc expression in NT2/D1 cells, while 
24 h treatment with 10 and 20 mM LiCl significantly 
increased the c-myc protein level (Fig. 3B). It has 
been previously shown that treatment of Caco-2 and 
SW480 cells with LiCl resulted in significant increas-
es in c-myc mRNA expression (Brookes et al., 2008). 
In addition, LiCl acting as a GSK 3b inhibitor pre-
vents the phosphorylation of c-myc and abrogates its 
proteasomal degradation. This leads to an increase 
in c-myc protein in HCT116 cells. In three human 
NSCLC (non-small-cell lung cancer) cell lines, treat-
ment with LiCl increased the expressions of c-myc 
at both the mRNA and the protein levels (Li et al., 
2011).
In this study we demonstrated that quercetin and 
lithium chloride significantly modulate Wnt signal-
ing in NT2/D1 cells and could be used as potent and 
efficient modulators of the canonical Wnt signaling 
pathway in these cells. According to our data, the 
concentrations of these agents that efficiently modu-
late Wnt signaling are 70 μM for quercetin and 20 
mM for LiCl. At a concentration of 70 μM, querce-
tin decreased the NT2/D1 cell proliferation rate by 
approximately 30% and significantly reduced the c-
myc protein level. At a quercetin concentration of 
100 μM, c-myc protein expression was completely 
reduced, indicating that Wnt signaling is efficiently 
inhibited. However, at this concentration quercetin 
cytotoxicity was very high, with a NT2/D1 cell vi-
ability of 40%.
The concentration of 20 mM LiCl considerably 
increased the c-myc protein level with a 30% de-
crease in the proliferation rate of NT2/D1 cells. On 
the other hand, at concentrations of 7 mM and 10 
mM, LiCl displayed no effect on the cell proliferation 
rate (low cytotoxity) while Wnt signaling activation 
was low sinca small increase in the c-myc protein 
level was detected.
The  canonical  Wnt  signaling  pathway  has  ap-
peared as a critical regulator of stem cell differen-
tiation. Also, it has been previously shown that the 
expression profile of multiple Wnt genes is dramati-
cally changed during the early phase of neuronal dif-
ferentiation of NT2/D1 cells (Katoh, 2002). The sum 
effect of these changes likely determined the fate of 
NT2/D1 cells: self-renewal or differentiation. Since 
the retinoic acid induction of NT2/D1 cells is a good 
in vitro model system for human neural differentia-MODULATIONS OF WNT SIGNALING IN NT2/D1 CELLS 207
tion, studying modulation of Wnt signaling in NT2/
D1 could contribute to a better understanding of the 
mechanisms  involved  in  neural  stem  cell  mainte-
nance and human neural development. Our results 
show that quercetin and lithium chloride treatments 
of NT2/D1 cells are efficient methods for Wnt signal-
ing modulations in NT2/D1 cells. Future studies will 
reveal how these modulations affect the expression 
of genes involved in retinoic acid-induced neural dif-
ferentiation of NT2/D1 cells.
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